The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis

Neuroepidemiology

Volumn 27, Issue 1, 2006, Pages 45-54

  Binquet, C ^a   Quantin, C ^a   Le Teuff, G ^a   Pagliano, J F ^a   Abrahamowicz, M ^b   Moreau, T ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Disability; First interattack interval; Multiple sclerosis, prognosis; Number of relapses; Time dependent Cox model

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEWBORN; ONSET AGE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RELAPSE;

ADOLESCENT; ADULT; AGE OF ONSET; CANADA; CATCHMENT AREA (HEALTH); CHILD; DATABASES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROGNOSIS; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 33746381172     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094380     Document Type: Article

References (32)

1. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal transaction in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
2. Confavreux C, Aimard G, Devic M: Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980;103:281-300.
3. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
4. Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
5. Confavreux C, Vukusic S, Moreau T, Adeleine P: Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-1438.
6. Janssens AC, van Doorn PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ: Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression, and disease-related distress. J Clin Epidemiol 2004;57:180-186.
7. Confavreux C, Vukusic S, Adeleine P: Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126:770-782.
8. Trojano M, Avolio C, Manzari C, Calo A, De Robertis F, Serio G, Livrea P: Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 1995;58:300-306.
9. Riise T, Gronning M, Fernandez O, Lauer K, Midgard R, Minderhoud JM, Nyland H, Palffy G, Poser S, Aarli JA: Early prognostic factors for disability in multiple sclerosis, a European multicenter study. Acta Neurol Scand 1992;85:212-218.
10. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;114:1045-1056.
11. Phadke JG: Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain 1990;113:1597-1628.
12. Amato MP, Ponziani G: A prospective study on the prognosis of multiple sclerosis. Neurol Sci 2000;21:S831-838.
13. Eriksson M, Andersen O, Runmarker B: Long-term follow-up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003;9:260-273.
14. Myhr K, Riise T, Vedeler C, Nortvedt M, Gronning M, Midgard R, Nyland H: Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 2001;7:59-65.
15. Runmarker B, Andersen O: Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116:117-134.
16. Simone I, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, Bellacosa A, Ceccarelli A, Pavone I, Livrea P: Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002;59:1922-1928.
17. Pittock S, Mayr W, McClelland R, Jorgensen N, Weigand S, Noseworthy J, Weinsheker B, Rodriguez M: Change in MS-related disability in a population-based cohort: a 10 year follow-up study. Neurology 2004;62:51-59.
18. Weinshenker BG, Ebers GC: The natural history of multiple sclerosis. Can J Neurol Sci 1987;14:255-261.
19. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
20. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
21. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ: EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55:671-676.
22. Confavreux C: Establishment and use of multiple sclerosis registers - EDMUS. Ann Neurol 1994;36:S136-139.
23. Hobart J, Lambling D, Thompson A: Evaluating neurological outcome measures: the bare essentials. J Neurol Neurosurg Psychiatry 1996;60:127-130.
24. Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkan J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E: Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996;40:469-479.
25. Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkan J, Rao S, Reingold S, Syndulko K, Thompson A, Wallemberg J, Weinsheker B, Willoughby E: Recommendations from the National Multiple Sclerosis Society clinical outcomes assessment task force. Ann Neurol 1997;42:379-382.
26. Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung HP, Kappos L, Thompson A, Trojano M, Vukusic S, Confavreux C: European validation of a standardized clinical description of multiple sclerosis. J Neurol 2004;251:1472-1480.
27. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
28. Cox DR: Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
29. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-1428.
30. Dancourt V, Quantin C, Abrahamowicz M, Binquet C, Alioum A, Faivre J: Modeling recurrence in colo-rectal cancer. J Cancer Epidemiol 2004;57:243-251.
31. Day N, Walter S: Simplified models of screening for chronic disease: estimation procedures from mass screening programs. Biometrics 1984;40:1-14.
32. Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B: Modeling smoking history: a comparison of different approaches. Am J Epidemiol 2002;156:813-823.